Year: 2008

Zydus Cadila – India’s 4th largest pharmaceutical group and a global healthcare provider, announced its foray into Spain with the acquisition of 100% stake in Laboratories Combix.

Laboratories Combix which has a pure generics focus provides the right fit for Zydus’ entry strategy into a market that is estimated at $ 1.7 billion and is growing at 21.5% compared to 6% for the overall pharmaceutical market in 2007. The Spanish pharmaceutical market is the 5th largest in Europe.

Established in 2006, Combix with a sales and marketing focus has a solid portfolio covering 17 molecules. Additionally, it has a range of products that are pending launch or in the pipeline. The acquisition allows Zydus to jumpstart its business and leverage strengths in product development, a high quality, cost-competitive supply chain and operational efficiency.

With the Government of India creating un-necessary hurdles in allotting barren lands to Corporates, companies are looking overseas for land acquisitions for their global dreams. Just a while ago, we have been informed by the management of Karuturi Global Ltd that the Company has completed its acquisition of 100,000 acres of land in Ethiopia, for cultivation of rice, vegetables, palm oil and sugarcane. The Company is in the process of acquiring a further land bank of 650,000 acres of land in Ethiopia.

At the time of declaring financial results for the year ended 31 March 2008 (FY 2008) during trading hours yesterday, 28 May 2008, Tata Motors announced plans to raise about Rs 7,200 crore through three simultaneous but unlinked rights issues to be used for financing the Jaguar-Land Rover acquisition. However the offer price, ratio and conversion prices of the rights issues will be announced later.

The first issue would consist of normal shares on a right basis amounting to Rs 2,200 crore. The second would raise up to Rs 2,000 crore through issue of “A” equity shares having one vote for every 10 shares. A further amount of Rs 3,000 crore is proposed to be raised through a third rights issue of five-year 0.5 per cent convertible preference shares (CCPs), optionally convertible into “A” equity shares after three years but before five years from the date of allotment.

The company had also proposed to raise about $500/600 million through an appropriate issue of securities in the foreign markets on terms to be decided at that time.